Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Covid-19: The Rollercoaster of Fibrin(Ogen), D-Dimer, Von Willebrand Factor, P-Selectin and Their Interactions with Endothelial Cells, Platelets and Erythrocytes
Corlia Grobler, Siphosethu Cassandra Maphumulo, Lize M. Grobbelaar, et al.
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 14, pp. 5168-5168
Open Access | Times Cited: 183

Showing 1-25 of 183 citing articles:

Long COVID or Post-acute Sequelae of COVID-19 (PASC): An Overview of Biological Factors That May Contribute to Persistent Symptoms
Amy D. Proal, Michael B. VanElzakker
Frontiers in Microbiology (2021) Vol. 12
Open Access | Times Cited: 743
Persistent clotting protein pathology in Long COVID/Post-Acute Sequelae of COVID-19 (PASC) is accompanied by increased levels of antiplasmin
Etheresia Pretorius, Maré Vlok, Chantelle Venter, et al.
Cardiovascular Diabetology (2021) Vol. 20, Iss. 1
Open Access | Times Cited: 401
Endothelial activation and dysfunction in COVID-19: from basic mechanisms to potential therapeutic approaches
Yuefei Jin, Wangquan Ji, Haiyan Yang, et al.
Signal Transduction and Targeted Therapy (2020) Vol. 5, Iss. 1
Open Access | Times Cited: 365
A central role for amyloid fibrin microclots in long COVID/PASC: origins and therapeutic implications
Douglas B. Kell, Gert Jacobus Laubscher, Etheresia Pretorius
Biochemical Journal (2022) Vol. 479, Iss. 4, pp. 537-559
Open Access | Times Cited: 210
Prevalence of symptoms, comorbidities, fibrin amyloid microclots and platelet pathology in individuals with Long COVID/Post-Acute Sequelae of COVID-19 (PASC)
Etheresia Pretorius, Chantelle Venter, Gert Jacobus Laubscher, et al.
Cardiovascular Diabetology (2022) Vol. 21, Iss. 1
Open Access | Times Cited: 184
Long COVID: mechanisms, risk factors and recovery
Rónan Astin, Amitava Banerjee, Mark R. Baker, et al.
Experimental Physiology (2022) Vol. 108, Iss. 1, pp. 12-27
Open Access | Times Cited: 164
Interconnections between Inflammageing and Immunosenescence during Ageing
Thibault Teissier, Éric Boulanger, Lynne S. Cox
Cells (2022) Vol. 11, Iss. 3, pp. 359-359
Open Access | Times Cited: 162
SARS-CoV-2 spike protein S1 induces fibrin(ogen) resistant to fibrinolysis: implications for microclot formation in COVID-19
Lize M. Grobbelaar, Chantelle Venter, Maré Vlok, et al.
Bioscience Reports (2021) Vol. 41, Iss. 8
Open Access | Times Cited: 156
Curcumin as a Potential Treatment for COVID-19
Bruna Rattis, Simone G. Ramos, Mara Rúbia Nunes Celes
Frontiers in Pharmacology (2021) Vol. 12
Open Access | Times Cited: 127
Proteomics of fibrin amyloid microclots in long COVID/post-acute sequelae of COVID-19 (PASC) shows many entrapped pro-inflammatory molecules that may also contribute to a failed fibrinolytic system
Arneaux Kruger, Maré Vlok, Simone Turner, et al.
Cardiovascular Diabetology (2022) Vol. 21, Iss. 1
Open Access | Times Cited: 115
The neuropsychiatric manifestations of COVID-19: Interactions with psychiatric illness and pharmacological treatment
Esmé Jansen van Vuren, Stephan F. Steyn, C. Brink, et al.
Biomedicine & Pharmacotherapy (2021) Vol. 135, pp. 111200-111200
Open Access | Times Cited: 97
Fibrinogen and Atherosclerotic Cardiovascular Diseases—Review of the Literature and Clinical Studies
Stanisław Surma, Maciej Banach
International Journal of Molecular Sciences (2021) Vol. 23, Iss. 1, pp. 193-193
Open Access | Times Cited: 94
Untargeted metabolomics of COVID-19 patient serum reveals potential prognostic markers of both severity and outcome
Ivayla Roberts, Marina Wright Muelas, Joseph M. Taylor, et al.
Metabolomics (2021) Vol. 18, Iss. 1
Open Access | Times Cited: 91
Erythrocyte, Platelet, Serum Ferritin, and P-Selectin Pathophysiology Implicated in Severe Hypercoagulation and Vascular Complications in COVID-19
Chantelle Venter, Johannes A. Bezuidenhout, Gert Jacobus Laubscher, et al.
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 21, pp. 8234-8234
Open Access | Times Cited: 86
Platelets and COVID-19
Anne‐Katrin Rohlfing, Dominik Rath, Tobias Geisler, et al.
Hämostaseologie (2021) Vol. 41, Iss. 05, pp. 379-385
Open Access | Times Cited: 67
Endothelial cells and SARS-CoV-2: An intimate relationship
Lucas Cunha Barbosa, Thaynan Lopes Gonçalves, Luanna Prudencio de Araújo, et al.
Vascular Pharmacology (2021) Vol. 137, pp. 106829-106829
Open Access | Times Cited: 66
Therapeutic Potential of Resveratrol in COVID-19-Associated Hemostatic Disorders
Roberta Giordo, Angelo Zinellu, Ali H. Eid, et al.
Molecules (2021) Vol. 26, Iss. 4, pp. 856-856
Open Access | Times Cited: 65
Hematological changes associated with COVID‐19 infection
Enass Abdul Kareem Dagher Al‐Saadi, Marwa Ali Abdulnabi
Journal of Clinical Laboratory Analysis (2021) Vol. 36, Iss. 1
Open Access | Times Cited: 61
Systemic Inflammation and COVID-19 Mortality in Patients with Major Noncommunicable Diseases: Chronic Coronary Syndromes, Diabetes and Obesity
Andreea Buicu, Simona Cernea, Imre Benedek, et al.
Journal of Clinical Medicine (2021) Vol. 10, Iss. 8, pp. 1545-1545
Open Access | Times Cited: 59
Covid‐19 and Liver Injury: Role of Inflammatory Endotheliopathy, Platelet Dysfunction, and Thrombosis
Matthew J. McConnell, Reiichiro Kondo, Nao Kawaguchi, et al.
Hepatology Communications (2021) Vol. 6, Iss. 2, pp. 255-269
Open Access | Times Cited: 56
An Insight into Recent Advances on Platelet Function in Health and Disease
Preeti Kumari Chaudhary, Sanggu Kim, Soochong Kim
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 11, pp. 6022-6022
Open Access | Times Cited: 56
The potential role of ischaemia–reperfusion injury in chronic, relapsing diseases such as rheumatoid arthritis, Long COVID, and ME/CFS: evidence, mechanisms, and therapeutic implications
Douglas B. Kell, Etheresia Pretorius
Biochemical Journal (2022) Vol. 479, Iss. 16, pp. 1653-1708
Open Access | Times Cited: 52
Hemolytic anemia in COVID-19
Hayder M. Al‐kuraishy, Ali I. Al‐Gareeb, Ajeet Kaushik, et al.
Annals of Hematology (2022) Vol. 101, Iss. 9, pp. 1887-1895
Open Access | Times Cited: 44
Relative Hypercoagulopathy of the SARS-CoV-2 Beta and Delta Variants when Compared to the Less Severe Omicron Variants Is Related to TEG Parameters, the Extent of Fibrin Amyloid Microclots, and the Severity of Clinical Illness
Lize M. Grobbelaar, Arneaux Kruger, Chantelle Venter, et al.
Seminars in Thrombosis and Hemostasis (2022) Vol. 48, Iss. 07, pp. 858-868
Open Access | Times Cited: 42
Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: the biology of a neglected disease
Hayley Arron, Benjamin D. Marsh, Douglas B. Kell, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 12
Page 1 - Next Page

Scroll to top